We report a
L-tryptophan-induced case of
eosinophilia-myalgia syndrome in a Japanese woman and describe the time course of changes in
tryptophan metabolism observed during
steroid therapy. She had taken 1.0 g of the implicated
L-tryptophan daily. When admitted due to painful swelling of her extremities, eosinophil count was 22.3 x 10(9)/L. Before
prednisolone treatment, her serum L-
kynurenine level was 10.2 mumol/L, a level about three-fold higher than the normal value, while serum
tryptophan level was abnormally low (23.1 mumol/L). On the 14th day of
prednisolone treatment (40 mg daily), L-
kynurenine was declined to 8.1 mumol/L and, concomitantly,
L-tryptophan level increased to the normal range (51.0 mumol/L). Subsequently, on the 42nd day of
therapy, serum L-
kynurenine was normalized. In contrast, serum
serotonin level was unchanged throughout the course of this
therapy.
Prednisolone dramatically reduced the elevated serum L-
kynurenine with a reciprocal increase in serum
L-tryptophan indicates that abnormal
tryptophan metabolism, may play a role in the pathogenesis of
eosinophilia myalgia syndrome, and that the observed effect of
steroid treatment was due to suppression of elevated activity of indoleamine 2, 3-dioxygenase, a first rate-limiting
enzyme of the
kynurenine pathway.